Stacy R. Lindborg's most recent trade in Imunon Inc was a trade of 75,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Imunon Inc | Stacy R. Lindborg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
Brainstorm Cell Therapeuti... | Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 20,000 | 48,229 (0%) | 0% | 0 | Common Stock | |
Imunon Inc | Stacy R. Lindborg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 63,602 | 302,768 | - | - | Stock Option (Right to Buy) | |
Imunon Inc | Stacy R. Lindborg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
Imunon Inc | Stacy R. Lindborg | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 16 Aug 2024 | 25,000 | 264,166 (0%) | 0% | 1.0 | 24,500 | Imunon Common Stock |
Imunon Inc | Stacy R. Lindborg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 112,500 | 239,166 | - | - | Stock Option (Right to Buy) | |
Imunon Inc | Stacy R. Lindborg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 112,500 | 126,666 | - | - | Stock Option (Right to Buy) | |
Imunon Inc | Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 4,500 | 14,166 | - | - | Stock Option (Right to Buy) | |
Brainstorm Cell Therapeuti... | Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 241,935 | 423,435 (1%) | 0% | 0 | Common Stock | |
Brainstorm Cell Therapeuti... | Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 35,000 | 170,000 (0%) | 0% | 0 | Common Stock | |
Brainstorm Cell Therapeuti... | Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 75,000 | 135,000 (0%) | 0% | 0 | Common Stock | |
Imunon Inc | Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 2,000 | 9,666 | - | - | Stock Option (Right to Buy) | |
Brainstorm Cell Therapeuti... | Stacy R. Lindborg | Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2022 | 35,000 | 60,000 (0%) | 0% | 0 | Common Stock | |
Imunon Inc | Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 2,500 | 7,666 | - | - | Option to Purchase Celsion Common Stock | |
Imunon Inc | Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 2,500 | 5,166 | - | - | Option to Purchase Celsion Corporation Common Stock | |
Imunon Inc | Stacy R. Lindborg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 40,000 | 40,000 | - | - | Option to Purchase Celsion Corporation Common Stock |